Precipio, Inc. (NASDAQ:PRPO) Short Interest Down 28.1% in November

Precipio, Inc. (NASDAQ:PRPO) saw a large drop in short interest in November. As of November 30th, there was short interest totalling 4,600 shares, a drop of 28.1% from the November 15th total of 6,400 shares. Approximately 0.4% of the shares of the stock are short sold. Based on an average trading volume of 6,800 shares, the days-to-cover ratio is currently 0.7 days.

Precipio Trading Down 3.5 %

NASDAQ PRPO traded down $0.22 on Friday, hitting $6.02. The company’s stock had a trading volume of 39,366 shares, compared to its average volume of 7,244. The company has a quick ratio of 0.60, a current ratio of 0.73 and a debt-to-equity ratio of 0.02. Precipio has a 1-year low of $4.31 and a 1-year high of $7.30. The firm has a market cap of $8.91 million, a PE ratio of -3.14 and a beta of 1.40. The company’s 50-day moving average is $6.26 and its 200 day moving average is $5.89.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.